National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1153727

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1153727
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK4175 / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Blood pressure high (Medically treated)
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': ILPFIZER INC2021330263

Write-up: Was found lifeless in her home; This is a spontaneous report received from a non-contactable other health care professional via regulatory authorities. A 68-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, lot number: EK4175), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Medical history included high blood pressure, medically treated. Concomitant medications were not reported. The patient was found lifeless in her home on an unspecified date. Time range between the vaccination and adverse event was 10 days. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are needed. No further information is expected.; Sender''s Comments: The limited information in this report precludes a full assessment of the case. However, "death cause unknown" is processed as "related" until sufficient information becomes available to exclude a reasonable possibility of relatedness to BNT162B2. Case will be reassessed when follow-up information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: found lifeless in her home

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1153727&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166